CLOSE ×

    Oncology

    Adi Harel, S., Bossel Ben-Moshe, N., Aylon, Y., Bublik, D. R., Moskovits, N., Toperoff, G., . . . Oren, M. (2015).,Reactivation of epigenetically silenced miR-512 and miR-373 sensitizes lung cancer cells to cisplatin and restricts tumor growth.,Cell Death and Differentiation, 22(8), 1328-1340. doi:10.1038/cdd.2014.221 [doi]
    Barnea, I., Ben-Yosef, R., Karaush, V., Benhar, I., & Vexler, A. (2013).,Targeting EGFR-positive cancer cells with cetuximab-ZZ-PE38: Results of in vitro and in vivo studies.,Head & Neck, 35(8), 1171-1177. doi:10.1002/hed.23093 [doi]
    Barnea, I., Haif, S., Keshet, R., Karaush, V., Lev-Ari, S., Khafif, A., . . . Ben Yosef, R. (2013).,Targeting ErbB-1 and ErbB-4 in irradiated head and neck cancer: Results of in vitro and in vivo studies.,Head & Neck, 35(3), 399-407. doi:10.1002/hed.22967 [doi]
    Carosio, R., Pistoia, V., Orienti, I., Formelli, F., Cavadini, E., Mangraviti, S., . . . Zuccari, G. (2012).,Enhanced anti-neuroblastoma activity of a fenretinide complexed form after intravenous administration.,The Journal of Pharmacy and Pharmacology, 64(2), 228-236. doi:10.1111/j.2042-7158.2011.01403.x [doi]
    Dal Bello, M. G., Alama, A., Barletta, G., Coco, S., Truini, A., Vanni, I., . . . Grossi, F. (2015).,Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors.,International Journal of Cancer.Journal International Du Cancer, doi:10.1002/ijc.29647 [doi]
    Konson, A., Pradeep, S., & Seger, R. (2010).,Phosphomimetic mutants of pigment epithelium-derived factor with enhanced antiangiogenic activity as potent anticancer agents.,Cancer Research, 70(15), 6247-6257. doi:10.1158/0008-5472.CAN-10-0434 [doi]
    Lev-Ari, S., Starr, A., Katzburg, S., Berkovich, L., Rimmon, A., Ben-Yosef, R., . . . Earon, G. (2014).,Curcumin induces apoptosis and inhibits growth of orthotopic human non-small cell lung cancer xenografts.,The Journal of Nutritional Biochemistry, 25(8), 843-850. doi:10.1016/j.jnutbio.2014.03.014 [doi]
    Portella, L., Vitale, R., De Luca, S., D'Alterio, C., Ierano, C., Napolitano, M., . . . Scala, S. (2013).,Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastases.,PloS One, 8(9), e74548. doi:10.1371/journal.pone.0074548 [doi]
    Ruban, A., Berkutzki, T., Cooper, I., Mohar, B., & Teichberg, V. I. (2012).,Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas.,Investigational New Drugs, 30(6), 2226-2235. doi:10.1007/s10637-012-9799-5 [doi]
    Yan, S. B., Peek, V. L., Ajamie, R., Buchanan, S. G., Graff, J. R., Heidler, S. A., . . . Walgren, R. A. (2013).,LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models.,Investigational New Drugs, 31(4), 833-844. doi:10.1007/s10637-012-9912-9 [doi]

    Transplantation

    Aylon, Y., Sarver, A., Tovy, A., Ainbinder, E., & Oren, M. (2014).,Lats2 is critical for the pluripotency and proper differentiation of stem cells.,Cell Death and Differentiation, 21(4), 624-633. doi:10.1038/cdd.2013.188 [doi]
    Konson, A., Pradeep, S., & Seger, R. (2010).,Phosphomimetic mutants of pigment epithelium-derived factor with enhanced antiangiogenic activity as potent anticancer agents.,Cancer Research, 70(15), 6247-6257. doi:10.1158/0008-5472.CAN-10-0434 [doi]
    Vandenabeele, S. I., DeCock, H., Van Ham, L., Meyer, E., & Daminet, S. (2013).,Study of the behaviour of lesional and nonlesional skin of canine recurrent flank alopecia transplanted to athymic nude mice.,Veterinary Dermatology, 24(5), 507-e120. doi:10.1111/vde.12059 [doi]

    Tumor Cell Growth

    Baker, A. M., Bird, D., Welti, J. C., Gourlaouen, M., Lang, G., Murray, G. I., . . . Erler, J. T. (2013).,Lysyl oxidase plays a critical role in endothelial cell stimulation to drive tumor angiogenesis.,Cancer Research, 73(2), 583-594. doi:10.1158/0008-5472.CAN-12-2447 [doi]
    Ben-Yosef, R., Starr, A., Karaush, V., Loew, V., Lev-Ari, S., Barnea, I., . . . Vexler, A. (2007).,ErbB-4 may control behavior of prostate cancer cells and serve as a target for molecular therapy.,The Prostate, 67(8), 871-880. doi:10.1002/pros.20555 [doi]
    Bifulco, K., Longanesi-Cattani, I., Liguori, E., Arra, C., Rea, D., Masucci, M. T., . . . Carriero, M. V. (2013).,A urokinase receptor-derived peptide inhibiting VEGF-dependent directional migration and vascular sprouting.,Molecular Cancer Therapeutics, 12(10), 1981-1993. doi:10.1158/1535-7163.MCT-13-0077 [doi]
    Hardy, B., Raiter, A., Yakimov, M., Vilkin, A., & Niv, Y. (2012).,Colon cancer cells expressing cell surface GRP78 as a marker for reduced tumorigenicity.,Cellular Oncology (Dordrecht), 35(5), 345-354. doi:10.1007/s13402-012-0094-4 [doi]
    Vandsburger, M. H., Radoul, M., Addadi, Y., Mpofu, S., Cohen, B., Eilam, R., & Neeman, M. (2013).,Ovarian carcinoma: Quantitative biexponential MR imaging relaxometry reveals the dynamic recruitment of ferritin-expressing fibroblasts to the angiogenic rim of tumors.,Radiology, 268(3), 790-801. doi:10.1148/radiol.13122053 [doi]